The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BLNK, NXTC and ACB

Accesswire

Published

*NEW YORK, NY / ACCESSWIRE / October 11, 2020 /* The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. *If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.*

*Blink Charging Company (NASDAQ:BLNK)*
Class Period: March 6, 2020 - August 19, 2020
Lead Plaintiff Deadline: October 23, 2020

The BLNK lawsuit alleges that throughout the class period, Blink Charging Company made materially false and/or misleading statements and/or failed to disclose that: (i) many of Blink's charging stations are damaged, neglected, non-functional, inaccessible, nor non-accessible; (ii) Blink's purported partnerships and expansions with other companies were overstated; (iii) the purported growth of the Company's network has been overstated; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

*Learn about your recoverable losses in BLNK*: http://www.kleinstocklaw.com/pslra-1/blink-charging-company-loss-submission-form?id=10001&from=1

*Nextcure, Inc. (NASDAQ:NXTC)*
The Nextcure lawsuit was filed on behalf of investors who purchased Nextcure, Inc. (NASDAQ: NXTC) securities: (1) between November 5, 2019 and July 14, 2020, inclusive; and/or (2) pursuant or traceable to the company's secondary public offering declared effective on November 14, 2019.
Lead Plaintiff Deadline: November 20, 2020

Throughout the class period defendants' statements were materially misleading because the data Defendants possessed on its principle product candidate, NC318, showed a lack of efficacy and objective responses. Had the truth been revealed, the market would have seen that NC318 was not, in fact, effective in treating most tumor types, that the NC318 application was proving to be limited (if even useful at all), and, as a result, there was a significant realizable risk that NC318 would not be nearly as popular as then-existing blockbuster drugs, such as Keytruda.

*Learn about your recoverable losses in NXTC*: http://www.kleinstocklaw.com/pslra-1/nextcure-inc-loss-submission-form?id=10001&from=1

*Aurora Cannabis Inc. (NYSE:ACB)*
Class Period: February 13, 2020 - September 4, 2020
Lead Plaintiff Deadline: December 1, 2020

Throughout the class period, Aurora Cannabis Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Aurora had significantly overpaid for previous acquisitions and experienced degradation in certain assets, including its production facilities and inventory; (ii) the Company's purported "business transformation plan" and cost reset failed to mitigate the foregoing issues; (iii) accordingly, it was foreseeable that the Company would record significant goodwill and asset impairment charges; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

*Learn about your recoverable losses in ACB*: http://www.kleinstocklaw.com/pslra-1/aurora-cannabis-inc-loss-submission-form-2?id=10001&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

*SOURCE:* The Klein Law Firm
View source version on accesswire.com:
https://www.accesswire.com/610028/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-BLNK-NXTC-and-ACB

Full Article